Leica Biosystems PD-L1 BOND antibody

Wednesday, 05 December, 2018 | Supplied by: Leica Microsystems Pty Ltd


Leica Biosystems’ PD-L1 BOND antibody is designed for use on the company’s fully automated BOND IHC and ISH staining platform.

The PD-L1 (programmed death - ligand 1) antibody uses the MKP1A07310 (clone 73-10) expressed by Abcam on behalf of Merck KGaA, which owns all IP rights to this antibody. It joins the ALK (anaplastic lymphoma kinase) antibody as the latest addition to Novocastra’s growing lung menu of primary antibodies.

Leica Biosystems has optimised these two clones into a ready-to-use format for use on the BOND IHC and ISH staining platform. This allows labs to perform ALK and PD-L1 testing on the BOND system with rapid turnaround times, reliable staining and walk-away convenience.

Online: www.leica-microsystems.com
Phone: 1800 625 286
Related Products

Biosynth carbohydrates

Within the carbohydrate product range, Biosynth offers tools for glycobiology, chemo-enzymatic...

Cayman Chemical Stem Cell Small Molecule Screening Library

The screening library contains more than 140 small molecules that are known either to induce...

Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd